01 October 2020
08:18
–
The European drug watchdog will soon begin an accelerated evaluation of the potential Covid-19 vaccine that the British AstraZeneca and the University of Oxford are developing.
–
The European Medicines Agency (EMA) would, writes Bloomberg news agency, the ‘rolling review’ of the AstraZeneca-Oxford vaccine at the earliest this week.
–
Such a procedure allows the EMA as regulator to evaluate data while clinical tests are still running, with the advantage that it can estimate more quickly whether the vaccine is going in the right direction. Normally, the European Pharmaceutical Watchdog only scrutinizes a vaccine after a pharmaceutical company has completed all tests and provided all clinical data.
–
The European Commission previously negotiated a collective purchase deal for 300 million doses of the British vaccine candidate, which will be distributed among Member States according to population size. Of that our country buys 7.5 million doses On.
–
–
/data/photo/2020/09/24/5f6c55da030da.jpg?resize=150%2C150&ssl=1)
